Sustained ventricular tachycardia and its successful prophylaxis during high-dose bolus interleukin-2 therapy for metastatic renal cell carcinoma.

Oleksowicz, L

Sustained ventricular tachycardia and its successful prophylaxis during high-dose bolus interleukin-2 therapy for metastatic renal cell carcinoma. [electronic resource] - American journal of clinical oncology Feb 2000 - 34-6 p. digital

Publication Type: Case Reports; Journal Article

0277-3732

10.1097/00000421-200002000-00009 doi


Anti-Arrhythmia Agents--therapeutic use
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Humans
Interleukin-2--adverse effects
Kidney Neoplasms--drug therapy
Male
Middle Aged
Sotalol--therapeutic use
Tachycardia, Ventricular--chemically induced